In this article, we will take a look at the 10 best penny stocks that are currently offering more than 200% upside potential to investors. On March 25, Jimmy Lee, CEO of Wealth Consulting Group, had a discussion with BNN Bloomberg regarding the ongoing geopolitical conflicts in the Middle East and potential opportunities that could emerge once things settle down.
Lee indicated that the market meltdown stemming from geopolitical risks could open up avenues for investors to realign their investment strategies. Beyond that, the AI-linked selloff has also led to some compelling entry points across the technology landscape. He pointed towards the small-cap universe, which he feels is valued attractively at the moment. However, there is room for further upside if interest rates fall from current levels.
Lee spoke about the potential rebound across broader markets, and small-cap stocks in particular, once the ongoing conflicts are resolved. He emphasized the significance of the Strait of Hormuz by stating:
“If the Strait is fully reopened and shipping flows return to normal, I think oil prices will come down significantly. There could be some collateral damage, but overall, the concerns about persistently high oil prices would ease. That would be a major relief, and I think investors would become more optimistic. The stock market could rebound, and we would likely see continued broadening into areas offering more value than the large-cap tech names that have led over the past five years. I see small-cap stocks doing well, and we are positioned for cyclical sectors. We do not think we are heading into a recession, even though risks have increased somewhat.”
With that background, let’s explore our 10 Best Penny Stocks That Could Triple Your Money.
Photo by Mohamed Hadji on Unsplash
Our Methodology
To identify relevant stocks for this article, we conducted a sector-agnostic screening of U.S.-listed companies with share prices below $5 and market capitalizations above $200 million. Also, we shortlisted only stocks with at least 200% upside potential according to TipRanks consensus as of the March 26 closing. Finally, we selected 10 stocks with the highest upside and ranked them in ascending order.
Why are we interested in the stocks that hedge funds pile into? The reason is simple: our research has shown that we can outperform the market by imitating the top stock picks of the best hedge funds. Our quarterly newsletter’s strategy selects 14 small-cap and large-cap stocks every quarter and has returned 498.7% since May 2014, beating its benchmark by 303 percentage points (see more details here).
10. SKYX Platforms Corp. (NASDAQ:SKYX)
SKYX Platforms Corp. (NASDAQ:SKYX) is one of the 10 best penny stocks that could triple your money.
On March 11, SKYX Platforms Corp. (NASDAQ:SKYX) announced that it will supply its technologies to a new residential project in Pittsford, New York. The development project is led by Daniele Management & Development Group, which will include 171 units and a range of modern amenities.
SKYX is expected to provide around 10,000 units of its smart plug-and-play technologies, including lighting and related products, to support a more advanced, tech-enabled living environment across the project.
Back on February 19, SKYX Platforms Corp. (NASDAQ:SKYX) provided a corporate update covering recent events and future initiatives. Since September 30, the company has brought in over $33 million in cash from institutional and existing investors. This included a $25 million investment by one institutional investor at $2.50 per share of straight common stock, with no warrants. The Shaner Group, which owns and develops more than 70 hotels worldwide, led the $16.5 million investment.
SKYX Platforms Corp. (NASDAQ:SKYX) also extended and converted $13.5 million in notes that were coming due. This pushed out the maturity to 2030. The company will be releasing new AI-based software for its e-commerce site, which includes 60 websites. This is expected to increase conversion rates and sales by as much as 30 percent.
SKYX Platforms Corp. (NASDAQ:SKYX) provides a chain of safe-smart platform technologies. With its first- and second-generation technologies, electrically wired devices such as light fixtures and ceiling fans are installed and plugged into ceiling electrical outlet boxes. Additionally, it also supplies universal power plugs and receptacle products.
9. Akebia Therapeutics Inc. (NASDAQ:AKBA)
Akebia Therapeutics Inc. (NASDAQ:AKBA) is one of the 10 best penny stocks that could triple your money.
On February 26, Akebia Therapeutics Inc. (NASDAQ:AKBA) outlined its 2026 pipeline expansion and shared expectations for Vafseo data catalysts in the $1 billion dialysis market during its fourth quarter 2025 earnings call. The company reported a total of $227 million in net product revenue for the year, with Vafseo and Auryxia being major contributors.
Chief Executive Officer John Butler reported that it was an important year for Akebia, particularly due to the commercialization of Vafseo. He also reported that there is increasing evidence of Vafseo’s potential for becoming standard of care in what is a $1 billion U.S. opportunity post-TDAPA, when Vafseo is expected to be priced at about parity with ESA pricing.
The company also announced its pipeline for rare kidney diseases, including an R&D day scheduled for April 2 to discuss mid-stage assets such as praliciguat and AKB-097. Butler stated:
“At the ASN meeting in November, we presented a post-hoc hierarchical composite endpoint analysis where patients treated with Vafseo experienced a lower risk of dying or being hospitalized than patients treated with the ESA comparator.”
On February 25, BTIG reduced the firm’s price target on Akebia Therapeutics Inc. (NASDAQ:AKBA) from $5 to $4. The firm maintained its Buy rating on the stock, citing a new protocol from U.S. Renal Care that impacted dosing practices, leading to a decline in channel inventory and lower-than-expected Q4 revenue for Vafseo. It added that the inventory adjustment weighed on near-term results despite the company’s broader outlook remaining intact.
Akebia Therapeutics Inc. (NASDAQ:AKBA) concentrates on the development and commercialization of medicines for kidney diseases. Its product portfolio includes Vafseo (vadadustat) and Auryxia. Additionally, it is working on AKB-10108 for the treatment of retinopathy of prematurity in neonates and AKB-9090 for treating cardiac surgery-related acute kidney injury and acute respiratory distress syndrome, which is undergoing Phase 2 of its clinical trial.
8. Lineage Cell Therapeutics Inc. (NYSE:LCTX)
Lineage Cell Therapeutics Inc. (NYSE:LCTX) is one of the 10 best penny stocks that could triple your money.
On March 24, Lineage Cell Therapeutics Inc. (NYSE:LCTX) announced the launch of COR1, a new preclinical cell therapy program targeting corneal endothelial disease. The company is leveraging its proprietary AlloSCOPE platform to develop scalable off-the-shelf cell therapies aimed at addressing the global shortage of donor corneal cells. Management highlighted the program as a natural extension of its platform and a step toward expanding its presence in ophthalmology while supporting long-term growth. Commenting on the update, CEO Brian Culley stated:
“We have elected to advance the COR1 program into preclinical testing and we also believe the recent accomplishments reported with our AlloSCOPE “5D” manufacturing process could be applied to this program to further reduce production costs through large-scale production.”
Earlier on March 6, Lineage Cell Therapeutics Inc. (NYSE:LCTX) reported fourth quarter revenue of $6.6 million compared to $2.9 million last year. Chief Executive Officer Brian M. Culley stated that 2025 was a very productive year for the Lineage team. Culley emphasized that the company’s mission is to pioneer the emerging field of allogeneic cell therapy outside oncology by applying its proprietary cell manufacturing technology platform, AlloSCOPE, to the production and transplantation of differentiated cell types intended to replace cells a patient has lost or lost function of due to various conditions.
Lineage Cell Therapeutics Inc. (NYSE:LCTX) is working in the US and internationally on developing cell replacement therapies for critical illnesses. Its portfolio includes OpRegen in Phase 2a of clinical trial, OPC1 in Phase 1/2a multicenter clinical trial, ReSonance (ANP1) and PNC1, both in preclinical development stage, and is also developing RND1.
7. Gevo Inc. (NASDAQ:GEVO)
Gevo Inc. (NASDAQ:GEVO) is one of the 10 best penny stocks that could triple your money.
On March 19, Gevo Inc. (NASDAQ:GEVO) announced it is delivering sustainable fuels to global motorsports. Through the production and sale of its patented, unique racing fuel blendstock, the company generated $5 million in revenue in 2025. Global motorsports initiatives to use sustainable fuels continue with the start of the 2026 racing season, while MotoGP hopes to use 100% non-fossil fuels by 2027.
The 2026 Formula One season also began with drivers using cutting-edge sustainable fuel. IndyCar is still dedicated to using renewable fuels, while NASCAR has added zero-carbon bioethanol as a blending component.
Back on February 11, Gevo Inc. (NASDAQ:GEVO) announced the closing of a refinancing transaction aimed at simplifying its capital structure. The company redeemed about $68 million in bonds tied to its renewable natural gas unit, freeing up over $35 million in restricted cash without increasing overall debt. It also secured a $175 million loan facility with Orion Infrastructure Capital and a $20 million revolving credit line with Huntington National Bank to support working capital needs.
Gevo Inc. (NASDAQ:GEVO) works on abating carbon, providing different kinds of fuel, specific items for the food chain, hydrocarbons for gasoline, and plastic material. It is also engaged in the development, construction, and operation of Alcohol-to-Jet initiatives. Its GevoRNG segment works on converting methane emissions into renewable natural gas, whereas the Verity platform works on different sections of the supply chain.
6. SNDL Inc. (NASDAQ:SNDL)
SNDL Inc. (NASDAQ:SNDL) is one of the 10 best penny stocks that could triple your money.
On March 12, SNDL Inc. (NASDAQ:SNDL) reported its fourth quarter EPS of (6c), improving from (36c) last year, while revenue came in at $252.5 million compared to $257.7 million a year ago. The company highlighted continued progress in financial performance, with gains recorded across its income statement and free cash flows.
Management also shed light upon the ongoing efforts to strengthen the operations and position the business for long-term sustainable growth. Commenting on the progress, CEO Zach George stated:
“2025 represents another step forward in financial performance and strategic focus for SNDL (SNDL). We are pleased to report new records across our income statement and free cash flow, while continuing to transform our business to support long-term, sustainable, and profitable growth, we are strengthening our performance culture and organizational capabilities, providing a solid foundation as we continue to raise the bar toward our vision of becoming a global leader in our industry.”
SNDL Inc. (NASDAQ:SNDL) is engaged in producing, distributing, and selling cannabis products for adult and medicinal use. Through its retail banners, the company also sells beers, wines, and spirits. Through its corporate-owned and franchised stores, it also privately sells cannabis items and accessories for adult use. Additionally, it manufactures and sells vapes, pre-rolls, and flower while also providing proprietary cannabis processing services.
While we acknowledge the potential of SNDL to grow, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an AI stock that is more promising than SNDL and that has 100x upside potential, check out our report about the cheapest AI stock.
Click to continue reading and see the 5 Best Penny Stocks That Could Triple Your Money.
Hedge Fund Resource Center